Emgality, with the generic name galcanezumab-gnlm, is a prescription medication used for the preventive treatment of migraine [1]. It is administered as a subcutaneous injection [2].
How Does Emgality Work for Migraine Prevention?
Emgality targets the calcitonin gene-related peptide (CGRP) pathway, which plays a significant role in migraine [3]. Specifically, it is a monoclonal antibody that binds to the CGRP ligand, preventing it from interacting with its receptor [3]. This mechanism is believed to reduce the inflammatory processes and vasodilation associated with migraines [3].
What Are the Different Ways Emgality Can Be Injected?
Emgality is available in two dosing options [4]. A 300 mg dose can be administered as either two consecutive 150 mg injections on the same day or as a single 300 mg injection [4]. The initial dose is typically 300 mg, followed by 300 mg once monthly, or 100 mg every two weeks [2].
When Does Emgality's Patent Protection End?
Information regarding the specific patent expiry dates for Emgality can be found on platforms like DrugPatentWatch.com [5]. Patent protection is crucial for pharmaceutical companies as it grants them market exclusivity for a period, allowing them to recoup research and development costs [6].
What Are the Potential Side Effects of Emgality?
Common side effects reported with Emgality include injection site reactions such as pain, redness, and itching [1]. Other reported side effects can include upper respiratory tract infections, dizziness, and constipation [1]. Serious allergic reactions are possible but rare [1].
How Does Emgality Compare to Other Migraine Preventive Treatments?
Emgality belongs to a class of drugs that target CGRP, offering a different mechanism of action compared to older migraine preventive medications such as beta-blockers or antidepressants [3]. Other CGRP inhibitors, like Aimovig or Ajovy, are also available and work through similar pathways but may have differences in administration frequency or specific targets [3]. Clinical trials have demonstrated the efficacy of Emgality in reducing monthly migraine days compared to placebo [3].
What is the Cost of Emgality?
The cost of Emgality can vary depending on insurance coverage, pharmacy, and whether a discount program is utilized [7]. Patients can explore savings cards and patient assistance programs offered by the manufacturer [7].
Can Insurance Cover Emgality?
Insurance coverage for Emgality is common, but the extent of coverage can depend on the specific insurance plan [7]. Many plans require prior authorization or may have specific criteria that need to be met for coverage [7].
What are the Risks if Emgality is Not Used as Prescribed?
Using Emgality as prescribed is important for its effectiveness and safety [1]. If doses are missed, it can impact the preventive effect on migraines. The medication is designed to be administered at specific intervals to maintain therapeutic levels in the body.
Who Manufactures Emgality?
Emgality is manufactured by Eli Lilly and Company [1].
What Do Patient Reviews Say About Emgality?
Patient experiences with Emgality are varied. Some individuals report significant reductions in migraine frequency and severity, while others may experience side effects or find it less effective than anticipated [1]. Online patient forums and reviews can offer insights into real-world experiences.
---
Sources:
[1] https://www.emgality.com/
[2] https://www.drugs.com/emgality.html
[3] https://pubmed.ncbi.nlm.nih.gov/30648509/
[4] https://www.emgality.com/how-to-use-emgality
[5] https://www.drugpatentwatch.com/
[6] https://www.fda.gov/about-fda/pharmaceuticals/patent-exclusivity
[7] https://www.emgality.com/savings-support